These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 9097068)

  • 1. The course of major depression in diabetes.
    Lustman PJ; Griffith LS; Freedland KE; Clouse RE
    Gen Hosp Psychiatry; 1997 Mar; 19(2):138-43. PubMed ID: 9097068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trial.
    Lustman PJ; Griffith LS; Clouse RE; Freedland KE; Eisen SA; Rubin EH; Carney RM; McGill JB
    Psychosom Med; 1997; 59(3):241-50. PubMed ID: 9178335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Symptoms of major depression and tricyclic side effects in primary care patients.
    Rollman BL; Block MR; Schulberg HC
    J Gen Intern Med; 1997 May; 12(5):284-91. PubMed ID: 9159697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenomenology and severity of major depression and comorbid lifetime anxiety disorders in primary medical care practice.
    Brown C; Schulberg HC; Shear MK
    Anxiety; 1996; 2(5):210-8. PubMed ID: 9160625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns and predictors of remission, response and recovery in major depression treated with fluoxetine or nortriptyline.
    Joyce PR; Mulder RT; Luty SE; Sullivan PF; McKenzie JM; Abbott RM; Stevens IF
    Aust N Z J Psychiatry; 2002 Jun; 36(3):384-91. PubMed ID: 12060188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychiatric comorbidity as a predictor of clinical response to nortriptyline in treatment-resistant major depressive disorder.
    Papakostas GI; Petersen TJ; Farabaugh AH; Murakami JL; Pava JA; Alpert JE; Fava M; Nierenberg AA
    J Clin Psychiatry; 2003 Nov; 64(11):1357-61. PubMed ID: 14658951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind comparison of fluoxetine and nortriptyline in the treatment of moderate to severe major depression.
    Akhondzadeh S; Faraji H; Sadeghi M; Afkham K; Fakhrzadeh H; Kamalipour A
    J Clin Pharm Ther; 2003 Oct; 28(5):379-84. PubMed ID: 14632962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suicidal ideation during treatment of depression with escitalopram and nortriptyline in genome-based therapeutic drugs for depression (GENDEP): a clinical trial.
    Perroud N; Uher R; Marusic A; Rietschel M; Mors O; Henigsberg N; Hauser J; Maier W; Souery D; Placentino A; Szczepankiewicz A; Jorgensen L; Strohmaier J; Zobel A; Giovannini C; Elkin A; Gunasinghe C; Gray J; Campbell D; Gupta B; Farmer AE; McGuffin P; Aitchison KJ
    BMC Med; 2009 Oct; 7():60. PubMed ID: 19832967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treating depressed primary care patients improves their physical, mental, and social functioning.
    Coulehan JL; Schulberg HC; Block MR; Madonia MJ; Rodriguez E
    Arch Intern Med; 1997 May; 157(10):1113-20. PubMed ID: 9164377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The posttreatment illness course of depression in bereaved elders. High relapse/recurrence rates.
    Pasternak RE; Prigerson H; Hall M; Miller MD; Fasiczka A; Mazumdar S; Reynolds CF
    Am J Geriatr Psychiatry; 1997; 5(1):54-9. PubMed ID: 9169245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease.
    Roose SP; Laghrissi-Thode F; Kennedy JS; Nelson JC; Bigger JT; Pollock BG; Gaffney A; Narayan M; Finkel MS; McCafferty J; Gergel I
    JAMA; 1998 Jan; 279(4):287-91. PubMed ID: 9450712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preventing poststroke depression: a 12-week double-blind randomized treatment trial and 21-month follow-up.
    Narushima K; Kosier JT; Robinson RG
    J Nerv Ment Dis; 2002 May; 190(5):296-303. PubMed ID: 12011609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors influencing glycemic control in type 2 diabetes during acute- and maintenance-phase treatment of major depressive disorder with bupropion.
    Lustman PJ; Williams MM; Sayuk GS; Nix BD; Clouse RE
    Diabetes Care; 2007 Mar; 30(3):459-66. PubMed ID: 17327305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depression in adults with diabetes. Results of 5-yr follow-up study.
    Lustman PJ; Griffith LS; Clouse RE
    Diabetes Care; 1988 Sep; 11(8):605-12. PubMed ID: 3219966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Executive dysfunction and long-term outcomes of geriatric depression.
    Alexopoulos GS; Meyers BS; Young RC; Kalayam B; Kakuma T; Gabrielle M; Sirey JA; Hull J
    Arch Gen Psychiatry; 2000 Mar; 57(3):285-90. PubMed ID: 10711915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening and correlates of depression and HbA1 C in United Arab Emirates (UAE) women with diabetes.
    Hawamdeh S; Almakhzoomy I; Hayajneh Y
    Perspect Psychiatr Care; 2013 Oct; 49(4):262-8. PubMed ID: 25187447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: a randomized controlled trial in patients older than 59 years.
    Reynolds CF; Frank E; Perel JM; Imber SD; Cornes C; Miller MD; Mazumdar S; Houck PR; Dew MA; Stack JA; Pollock BG; Kupfer DJ
    JAMA; 1999 Jan; 281(1):39-45. PubMed ID: 9892449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nortriptyline for treatment-resistant depression.
    Nierenberg AA; Papakostas GI; Petersen T; Kelly KE; Iacoviello BM; Worthington JJ; Tedlow J; Alpert JE; Fava M
    J Clin Psychiatry; 2003 Jan; 64(1):35-9. PubMed ID: 12590621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two-year outcome of psychotic depression in late life.
    Flint AJ; Rifat SL
    Am J Psychiatry; 1998 Feb; 155(2):178-83. PubMed ID: 9464195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nortriptyline versus fluoxetine in the treatment of depression and in short-term recovery after stroke: a placebo-controlled, double-blind study.
    Robinson RG; Schultz SK; Castillo C; Kopel T; Kosier JT; Newman RM; Curdue K; Petracca G; Starkstein SE
    Am J Psychiatry; 2000 Mar; 157(3):351-9. PubMed ID: 10698809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.